You have 9 free searches left this month | for more free features.

capmatinib and spartalizumab

Showing 1 - 25 of 36

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Oesophageal Adenocarcinoma, Gastric Adenocarcinoma Trial in France (Capmatinib, Spartalizumab)

Suspended
  • Oesophageal Adenocarcinoma
  • Gastric Adenocarcinoma
  • Besançon, France
  • +6 more
Feb 1, 2023

NSCLC Trial in Worldwide (Capmatinib, Spartalizumab, Docetaxel)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Fayetteville, Arkansas
  • +7 more
Jan 21, 2022

Triple-negative Breast Cancer Trial in Worldwide (LAG525, Spartalizumab, Carboplatin)

Completed
  • Triple-negative Breast Cancer
  • Chandler, Arizona
  • +32 more
Jan 27, 2023

Capmatinib vs. Standard of Care for German Adult Locally

Completed
  • Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring METex14 Mutations
    • Berlin, Germany
    • +9 more
    Mar 22, 2023

    Tabrecta® (Capmatinib) in South Korea

    Not yet recruiting
    • Non-Small-Cell Lung Carcinoma
    • Capmatinib
    • (no location specified)
    Jan 19, 2023

    Glioblastoma Multiforme Trial in Stanford, Baltimore (MBG453)

    Active, not recruiting
    • Glioblastoma Multiforme
    • Stanford, California
    • +1 more
    Nov 22, 2022

    NSCLC Trial in Japan, Korea, Republic of, Singapore (capmatinib, pemetrexed, cisplatin)

    Terminated
    • Carcinoma, Non-Small-Cell Lung
    • Kashiwa, Chiba, Japan
    • +3 more
    Jan 31, 2023

    Non Small Cell Lung Cancer Trial in Worldwide (Capmatinib, Nazartinib)

    Terminated
    • Non Small Cell Lung Cancer
    • Boston, Massachusetts
    • +18 more
    Jul 20, 2022

    Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer Trial in San Francisco (Capmatinib, Trametinib)

    Recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • Stage IV Lung Cancer
    • San Francisco, California
      University of California San Francisco
    Aug 15, 2022

    Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, drug, biological)

    Not yet recruiting
    • Recurrent Lung Non-Small Cell Carcinoma
    • Stage IV Lung Cancer AJCC v8
    • Biospecimen Collection
    • +5 more
    • (no location specified)
    Nov 30, 2022

    Advanced Solid Tumors Trial in Worldwide (PDR001)

    Recruiting
    • Advanced Solid Tumors
    • New York, New York
    • +42 more
    Jan 23, 2023

    Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID

    Active, not recruiting
    • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 9, 2022

    NSCLC Trial in Pittsburgh (Capmatinib)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jan 9, 2023

    Carcinoma, Renal Cell Trial in New York (Spartalizumab, Canakinumab)

    Recruiting
    • Carcinoma, Renal Cell
    • New York, New York
      Columbia University Medical Center
    May 6, 2022

    Non-Small Cell Lung Carcinoma Trial (Capmatinib 150 mg, Capmatinib 200 mg)

    Recruiting
    • Non-Small Cell Lung Carcinoma
    • Capmatinib 150 mg
    • Capmatinib 200 mg
    • Guwahati, Assam, India
    • +7 more
    Dec 19, 2022

    Metastatic NSCLC MET Exon 14 Skipping Mutation and Brain

    Completed
    • Metastatic Non-Small Cell Lung Cancer
    • East Hanover, New Jersey
      18 Novartis Investigative Sites in the US
    Dec 29, 2022

    MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

    Active, not recruiting
    • MSI-H Colorectal Cancer
    • +30 more
    • Badalona, Barcelona, Spain
    • +9 more
    Oct 24, 2022

    NSCLC Trial in Worldwide (Capmatinib, Amivantamab)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Orange, California
    • +40 more
    Aug 3, 2022

    NSCLC (NSCLC) Trial in China (Capmatinib)

    Recruiting
    • Non-Small Cell Lung Cancer (NSCLC)
    • Xiamen, Fujian, China
    • +18 more
    Jan 27, 2023

    Advanced Solid Tumors Which Are cMET-dependent Trial in Worldwide (Capmatinib, Nazartinib, Gefitinib)

    Recruiting
    • Advanced Solid Tumors Which Are cMET-dependent
    • Boston, Massachusetts
    • +12 more
    Jan 27, 2023

    Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Atlanta (Siltuximab, Spartalizumab)

    Recruiting
    • Metastatic Pancreatic Adenocarcinoma
    • Stage IV Pancreatic Cancer AJCC v8
    • Siltuximab
    • Spartalizumab
    • Atlanta, Georgia
    • +2 more
    Feb 1, 2022

    NSCLC Trial in United States (capmatinib)

    Recruiting
    • Non-small Cell Lung Cancer
    • La Jolla, California
    • +7 more
    Oct 5, 2022

    Metastatic Breast Cancer, Breast Cancer Trial in Houston (Neratinib, Capmatinib)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Breast Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 16, 2022

    Head and Neck Squamous Cell Carcinoma Trial in Taipei (Ribociclib, Spartalizumab)

    Active, not recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Taipei, Taiwan
      National Taiwan University Hospital
    Apr 19, 2022

    Squamous Cell Anal Carcinoma, Metastatic Squamous Cell Carcinoma Trial in Besançon, Lyon, Montbeliard (Sample collection)

    Recruiting
    • Squamous Cell Anal Carcinoma
    • Metastatic Squamous Cell Carcinoma
    • Sample collection
    • Besançon, France
    • +2 more
    Mar 10, 2022